Orifarm: Class 4 Medicines Defect Information: Orifarm UK Ltd, Concerta XL 18mg & 36 mg prolonged release tablets
The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 4 Medicines defect information for Orifarm UK Ltd, Concerta XL 18mg & 36 mg prolonged release tablets. Orifarm
Read full article »
Orifarm is a provider of medical products such as prescription drugs and capsules for pharmacies and hospitals.
Read more